Mainz Biomed B.V.

• locale

  Germany

• market

  STOCKS

• industry

  Medical - Diagnostics & Research

• website

  mainzbiomed.com

• ipo date

  Nov 05, 2021

Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; an...Show More

*Estimate based on analyst consensus